首页 > 最新文献

Neurourology and Urodynamics最新文献

英文 中文
Sixteen Years of Multinational Experience in Female Genital Fistula Repair: Integrating Traditional and Innovative Surgical Approaches Across 12 Countries. 16年女性生殖瘘管修复的跨国经验:在12个国家整合传统和创新的手术方法。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-02 DOI: 10.1002/nau.70226
M Sherif Mourad, Mariam Malallah, Wally Mahfouz, Ahmed Saafan, Ahmed Farouk, Mohamed Yassin, Mohamed Metwaly, Hassan Shaker

Objectives: To present a 16-year multinational experience of 1185 female genital fistula (FGF) repairs performed by a single surgical team, emphasizing the integration of classical techniques with adjunctive innovations across diverse clinical settings.

Methods: This structured observational study included 1185 FGF repairs conducted from 2009 to 2025 across 12 countries. Data collected included patient demographics, fistula etiology and type, prior repairs, surgical approach, use of adjuncts, and postoperative outcomes. Primary outcomes were anatomical closure and functional recovery. Secondary outcomes included postoperative complications and psychosocial reintegration of the patients into their families and societies.

Results and limitations: Vesicovaginal fistulas accounted for 64% of cases, followed by urethrovaginal (12%) and rectovaginal (11%). Obstetric trauma and iatrogenic injury were the leading causes (59% and 34%, respectively). Fistulas were classified as simple (36%), recurrent (56%), or complex (8%). Overall closure rate was 82%, highest among simple (91%) and primary (85%) cases. Adjuncts such as platelet-rich plasma (PRP), small intestinal submucosa (SIS), fibrin glue, and buccal grafts were used in 71% of complex/recurrent repairs, with a 72% closure rate in this subgroup. Residual incontinence after successful closure of fistula affected 12% of patients, most of whom improved with bulking agents (72%) or pubovaginal slings (91%). Complication rates included urinary tract and wound infections (5%) and recurrence of fistula (18%). Limitations include retrospective design and heterogeneity in adjunct usage. Another main limitation is our follow-up regimen, which was not done by our surgical team in all countries included. Nevertheless, treatment of residual incontinence was not performed solely by our team, and thus this affected success rate of residual incontinence.

Conclusions: Combining traditional surgical methods with adjunctive techniques enables high closure and functional recovery rates in FGF repair, even in low-resource settings. Selective use of adjuncts supports tissue healing in complex cases and may enhance long-term success.

Patient summary: In this multinational study of 1185 FGF surgeries, integrating traditional and innovative techniques led to high closure rates and improved continence and quality of life even in resource-constrained countries.

Clinical registration: This study does not require clinical trial registration as it is an observational, retrospective analysis of anonymized surgical cases (2009-2025).

目的:介绍16年来由一个外科团队完成的1185例女性生殖器瘘(FGF)修复的跨国经验,强调在不同临床环境下经典技术与辅助创新的整合。方法:这项结构化观察性研究包括2009年至2025年在12个国家进行的1185例FGF修复。收集的数据包括患者人口统计学、瘘管病因和类型、既往修复、手术入路、辅助工具的使用和术后结果。主要结果为解剖闭合和功能恢复。次要结局包括术后并发症和患者重返家庭和社会的心理社会。结果与局限性:膀胱阴道瘘占64%,其次是尿道阴道瘘(12%)和直肠阴道瘘(11%)。产科创伤和医源性损伤是主要原因(分别为59%和34%)。瘘管分为单纯性(36%)、复发性(56%)和复合性(8%)。总结扎率为82%,单纯性(91%)和原发性(85%)最高。辅助材料如富血小板血浆(PRP)、小肠粘膜下层(SIS)、纤维蛋白胶和颊移植物用于71%的复杂/复发修复,该亚组的闭合率为72%。12%的患者在成功关闭瘘管后出现残留失禁,其中大多数患者使用膨化剂(72%)或阴阴道吊带(91%)得到改善。并发症发生率包括尿路和伤口感染(5%)和瘘管复发(18%)。局限性包括回顾性设计和辅助使用的异质性。另一个主要限制是我们的随访方案,并不是我们的外科团队在所有纳入的国家都这样做。然而,残余尿失禁的治疗不是由我们的团队单独进行的,因此这影响了残余尿失禁的成功率。结论:将传统手术方法与辅助技术相结合,即使在资源匮乏的情况下,FGF修复的闭合率和功能恢复率也很高。选择性使用辅助材料支持复杂病例的组织愈合,并可能提高长期的成功。患者总结:在这项涉及1185例FGF手术的跨国研究中,即使在资源受限的国家,传统和创新技术的结合也能提高闭合率,改善自理和生活质量。临床注册:本研究不需要临床试验注册,因为它是对匿名手术病例(2009-2025)的观察性回顾性分析。
{"title":"Sixteen Years of Multinational Experience in Female Genital Fistula Repair: Integrating Traditional and Innovative Surgical Approaches Across 12 Countries.","authors":"M Sherif Mourad, Mariam Malallah, Wally Mahfouz, Ahmed Saafan, Ahmed Farouk, Mohamed Yassin, Mohamed Metwaly, Hassan Shaker","doi":"10.1002/nau.70226","DOIUrl":"https://doi.org/10.1002/nau.70226","url":null,"abstract":"<p><strong>Objectives: </strong>To present a 16-year multinational experience of 1185 female genital fistula (FGF) repairs performed by a single surgical team, emphasizing the integration of classical techniques with adjunctive innovations across diverse clinical settings.</p><p><strong>Methods: </strong>This structured observational study included 1185 FGF repairs conducted from 2009 to 2025 across 12 countries. Data collected included patient demographics, fistula etiology and type, prior repairs, surgical approach, use of adjuncts, and postoperative outcomes. Primary outcomes were anatomical closure and functional recovery. Secondary outcomes included postoperative complications and psychosocial reintegration of the patients into their families and societies.</p><p><strong>Results and limitations: </strong>Vesicovaginal fistulas accounted for 64% of cases, followed by urethrovaginal (12%) and rectovaginal (11%). Obstetric trauma and iatrogenic injury were the leading causes (59% and 34%, respectively). Fistulas were classified as simple (36%), recurrent (56%), or complex (8%). Overall closure rate was 82%, highest among simple (91%) and primary (85%) cases. Adjuncts such as platelet-rich plasma (PRP), small intestinal submucosa (SIS), fibrin glue, and buccal grafts were used in 71% of complex/recurrent repairs, with a 72% closure rate in this subgroup. Residual incontinence after successful closure of fistula affected 12% of patients, most of whom improved with bulking agents (72%) or pubovaginal slings (91%). Complication rates included urinary tract and wound infections (5%) and recurrence of fistula (18%). Limitations include retrospective design and heterogeneity in adjunct usage. Another main limitation is our follow-up regimen, which was not done by our surgical team in all countries included. Nevertheless, treatment of residual incontinence was not performed solely by our team, and thus this affected success rate of residual incontinence.</p><p><strong>Conclusions: </strong>Combining traditional surgical methods with adjunctive techniques enables high closure and functional recovery rates in FGF repair, even in low-resource settings. Selective use of adjuncts supports tissue healing in complex cases and may enhance long-term success.</p><p><strong>Patient summary: </strong>In this multinational study of 1185 FGF surgeries, integrating traditional and innovative techniques led to high closure rates and improved continence and quality of life even in resource-constrained countries.</p><p><strong>Clinical registration: </strong>This study does not require clinical trial registration as it is an observational, retrospective analysis of anonymized surgical cases (2009-2025).</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146106617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Influence of Preoperative Urodynamics on Management in Women With Pelvic Organ Prolapse. 术前尿动力学对女性盆腔器官脱垂治疗的影响。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-07-07 DOI: 10.1002/nau.70115
Apisith Saraluck, Jittima Manonai

Importance: The role of preoperative urodynamic studies (UDS) in women undergoing pelvic organ prolapse (POP) surgery remains controversial, especially regarding their influence on surgical planning and patient counseling.

Objective: To evaluate the impact of preoperative UDS on changes in surgical management and counseling among women with advanced-stage POP undergoing surgical repair.

Design: Retrospective observational study.

Setting: Tertiary urogynecology center at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Participants: A total of 118 women with POP-Q stage III or IV who underwent UDS before planned POP surgery between July 2018 and July 2023.

Interventions: All participants underwent standardized multichannel UDS, including POP reduction during testing, based on institutional protocol and international guidelines.

Main outcomes and measures: The primary outcome was the proportion of cases in which UDS findings led to changes in surgical or medical management. Secondary outcomes included the role of UDS in enhancing preoperative counseling and identifying discrepancies between symptoms and objective findings.

Results: The mean age of participants was 69.4 years (SD 7.7), with 97.5% being postmenopausal. UDS altered clinical management in 23 cases (19.5%). Notable changes included the addition or omission of anti-incontinence procedures and initiation of OAB treatment. UDS also enhanced the preoperative counseling process, contributing to informed decision-making in 67 patients (56.8%) and excluding misleading symptoms in 69 cases (58.5%), such as absence of detrusor overactivity in OAB or detrusor underactivity in voiding dysfunction.

Conclusions and relevance: Preoperative UDS led to management changes in approximately one in five patients with advanced POP, particularly those with SUI, occult SUI, or voiding dysfunction. Although major surgical changes were infrequent, UDS provided significant value for patient counseling and risk stratification. These findings support a more selective and context-specific approach to the use of UDS in POP surgical planning.

重要性:术前尿动力学研究(UDS)在女性盆腔器官脱垂(POP)手术中的作用仍然存在争议,特别是它们对手术计划和患者咨询的影响。目的:评价术前UDS对晚期POP手术修复妇女手术管理和咨询改变的影响。设计:回顾性观察性研究。地点:泰国曼谷玛希隆大学Ramathibodi医院第三泌尿妇科中心。参与者:2018年7月至2023年7月期间,共有118名POP- q期III或IV期女性在计划的POP手术前接受了UDS。干预措施:所有参与者都进行了标准化的多通道UDS,包括在测试期间减少POP,基于机构协议和国际指南。主要结局和措施:主要结局是UDS检查结果导致手术或医疗管理改变的病例比例。次要结果包括UDS在加强术前咨询和识别症状与客观结果之间差异方面的作用。结果:参与者的平均年龄为69.4岁(SD 7.7), 97.5%为绝经后。UDS改变临床管理23例(19.5%)。值得注意的变化包括增加或遗漏反尿失禁程序和开始OAB治疗。UDS还加强了术前咨询过程,有助于67例患者(56.8%)做出明智的决策,并排除了69例患者(58.5%)的误导性症状,例如OAB患者没有逼尿肌过度活动或排尿功能障碍患者没有逼尿肌活动不足。结论和相关性:术前UDS导致大约五分之一的晚期POP患者的管理改变,特别是那些有SUI、隐匿性SUI或排尿功能障碍的患者。虽然大的手术改变并不常见,但UDS为患者咨询和风险分层提供了重要的价值。这些发现支持了在POP手术计划中使用UDS的更有选择性和具体情况的方法。
{"title":"The Influence of Preoperative Urodynamics on Management in Women With Pelvic Organ Prolapse.","authors":"Apisith Saraluck, Jittima Manonai","doi":"10.1002/nau.70115","DOIUrl":"10.1002/nau.70115","url":null,"abstract":"<p><strong>Importance: </strong>The role of preoperative urodynamic studies (UDS) in women undergoing pelvic organ prolapse (POP) surgery remains controversial, especially regarding their influence on surgical planning and patient counseling.</p><p><strong>Objective: </strong>To evaluate the impact of preoperative UDS on changes in surgical management and counseling among women with advanced-stage POP undergoing surgical repair.</p><p><strong>Design: </strong>Retrospective observational study.</p><p><strong>Setting: </strong>Tertiary urogynecology center at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</p><p><strong>Participants: </strong>A total of 118 women with POP-Q stage III or IV who underwent UDS before planned POP surgery between July 2018 and July 2023.</p><p><strong>Interventions: </strong>All participants underwent standardized multichannel UDS, including POP reduction during testing, based on institutional protocol and international guidelines.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was the proportion of cases in which UDS findings led to changes in surgical or medical management. Secondary outcomes included the role of UDS in enhancing preoperative counseling and identifying discrepancies between symptoms and objective findings.</p><p><strong>Results: </strong>The mean age of participants was 69.4 years (SD 7.7), with 97.5% being postmenopausal. UDS altered clinical management in 23 cases (19.5%). Notable changes included the addition or omission of anti-incontinence procedures and initiation of OAB treatment. UDS also enhanced the preoperative counseling process, contributing to informed decision-making in 67 patients (56.8%) and excluding misleading symptoms in 69 cases (58.5%), such as absence of detrusor overactivity in OAB or detrusor underactivity in voiding dysfunction.</p><p><strong>Conclusions and relevance: </strong>Preoperative UDS led to management changes in approximately one in five patients with advanced POP, particularly those with SUI, occult SUI, or voiding dysfunction. Although major surgical changes were infrequent, UDS provided significant value for patient counseling and risk stratification. These findings support a more selective and context-specific approach to the use of UDS in POP surgical planning.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"379-384"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144575938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detrusor Overactivity and Urodynamics. 逼尿肌过度活动和尿动力学。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-07-03 DOI: 10.1002/nau.70113
Laura N Nguyen, Geneviève Nadeau

While overactive bladder (OAB) is a clinical diagnosis, detrusor overactivity is identified through urodynamic testing. UDS is usually considered when primary treatment for OAB fails, because UDS is expensive, time consuming, invasive, and sometimes inaccurate, and it is not considered to influence treatment strategy substantially. On the other hand, UDS helps for diagnosis and treatment among women with OAB symptoms, and plays a key role in diagnosing DO to properly assess bladder function for complex LUTS situations such as nocturnal enuresis, bladder outlet obstruction, detrusor underactivity or after surgical correction of stress urinary incontinence. This article emphasizes the vital role of urodynamics in diagnosing and managing DO, highlighting its significance in treatment planning and the need for further research to refine diagnostic criteria and therapeutic strategies.

虽然膀胱过动症(OAB)是一种临床诊断,但逼尿肌过动症是通过尿动力学测试来确定的。当OAB的初级治疗失败时,通常会考虑UDS,因为UDS昂贵、耗时、有创且有时不准确,并且不会被认为对治疗策略产生重大影响。另一方面,UDS有助于有OAB症状的女性的诊断和治疗,对于夜间尿潴留、膀胱出口梗阻、逼尿肌活动不足等复杂LUTS情况,或手术矫正应激性尿失禁后,在诊断DO、正确评估膀胱功能方面发挥关键作用。本文强调尿动力学在诊断和管理DO中的重要作用,强调其在治疗计划中的重要性,以及进一步研究以完善诊断标准和治疗策略的必要性。
{"title":"Detrusor Overactivity and Urodynamics.","authors":"Laura N Nguyen, Geneviève Nadeau","doi":"10.1002/nau.70113","DOIUrl":"10.1002/nau.70113","url":null,"abstract":"<p><p>While overactive bladder (OAB) is a clinical diagnosis, detrusor overactivity is identified through urodynamic testing. UDS is usually considered when primary treatment for OAB fails, because UDS is expensive, time consuming, invasive, and sometimes inaccurate, and it is not considered to influence treatment strategy substantially. On the other hand, UDS helps for diagnosis and treatment among women with OAB symptoms, and plays a key role in diagnosing DO to properly assess bladder function for complex LUTS situations such as nocturnal enuresis, bladder outlet obstruction, detrusor underactivity or after surgical correction of stress urinary incontinence. This article emphasizes the vital role of urodynamics in diagnosing and managing DO, highlighting its significance in treatment planning and the need for further research to refine diagnostic criteria and therapeutic strategies.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"279-285"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144554026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Future of Urodynamics: Innovations, Challenges, and Possibilities. 尿动力学的未来:创新、挑战和可能性。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-05-14 DOI: 10.1002/nau.70074
Lauren E Chew, Jessica H Hannick, Lynn L Woo, John K Weaver, Margot S Damaser

Introduction: Urodynamic studies (UDS) are essential for evaluating lower urinary tract function but are limited by patient discomfort, lack of standardization and diagnostic variability. Advances in technology aim to address these challenges and improve diagnostic accuracy and patient comfort.

Ambulatory urodynamic monitoring (aum): AUM offers physiological assessment by allowing natural bladder filling and monitoring during daily activities. Compared to conventional UDS, AUM demonstrates higher sensitivity for detecting detrusor overactivity and underlying pathophysiology. However, it faces challenges like motion artifacts, catheter-related discomfort, and difficulty measuring continuous bladder volume.

Remote monitoring technologies: Emerging devices such as Urodynamics Monitor and UroSound offer more patient-friendly alternatives. These tools have the potential to improve diagnostic accuracy for bladder pressure and voiding metrics but remain limited and still require further validation and testing.

Ultrasonography in uds: Ultrasound-based modalities, including dynamic ultrasonography and shear wave elastography, provide real-time, noninvasive assessment of bladder structure and function. These modalities are promising but will require further development of standardized protocols.

Artificial intelligence in uds: AI and machine learning models enhance diagnostic accuracy and reduce variability in UDS interpretation. Applications include detecting detrusor overactivity and distinguishing bladder outlet obstruction from detrusor underactivity. However, further validation is required for clinical adoption.

Conclusion: Advances in AUM, wearable technologies, ultrasonography, and AI demonstrate potential for transforming UDS into a more accurate, patient-centered tool. Despite significant progress, challenges like technical complexity, standardization, and cost-effectiveness must be addressed to integrate these innovations into routine practice. Nonetheless, these technologies provide the possibility of a future of improved diagnosis and treatment of lower urinary tract dysfunction.

导读:尿动力学研究(UDS)对评估下尿路功能至关重要,但受患者不适、缺乏标准化和诊断可变性的限制。技术的进步旨在解决这些挑战,提高诊断的准确性和患者的舒适度。动态尿动力学监测(aum): aum提供生理评估,允许膀胱自然充盈和监测日常活动。与传统UDS相比,AUM在检测逼尿肌过度活动和潜在病理生理方面表现出更高的灵敏度。然而,它面临着诸如运动伪影、导尿管相关的不适以及难以测量连续膀胱容量等挑战。远程监控技术:新兴设备如Urodynamics Monitor和UroSound为患者提供了更友好的选择。这些工具有可能提高膀胱压力和排尿指标的诊断准确性,但仍然有限,仍需要进一步的验证和测试。超声检查:基于超声的方式,包括动态超声检查和横波弹性成像,提供实时、无创的膀胱结构和功能评估。这些模式很有希望,但需要进一步制定标准化协议。uds中的人工智能:人工智能和机器学习模型提高了uds的诊断准确性,减少了uds解释的可变性。应用包括检测逼尿肌过度活动和区分膀胱出口阻塞和逼尿肌活动不足。然而,临床应用需要进一步的验证。结论:AUM、可穿戴技术、超声技术和人工智能的进步显示了将UDS转变为更准确、以患者为中心的工具的潜力。尽管取得了重大进展,但必须解决技术复杂性、标准化和成本效益等挑战,以便将这些创新整合到日常实践中。尽管如此,这些技术为改善下尿路功能障碍的诊断和治疗提供了未来的可能性。
{"title":"The Future of Urodynamics: Innovations, Challenges, and Possibilities.","authors":"Lauren E Chew, Jessica H Hannick, Lynn L Woo, John K Weaver, Margot S Damaser","doi":"10.1002/nau.70074","DOIUrl":"10.1002/nau.70074","url":null,"abstract":"<p><strong>Introduction: </strong>Urodynamic studies (UDS) are essential for evaluating lower urinary tract function but are limited by patient discomfort, lack of standardization and diagnostic variability. Advances in technology aim to address these challenges and improve diagnostic accuracy and patient comfort.</p><p><strong>Ambulatory urodynamic monitoring (aum): </strong>AUM offers physiological assessment by allowing natural bladder filling and monitoring during daily activities. Compared to conventional UDS, AUM demonstrates higher sensitivity for detecting detrusor overactivity and underlying pathophysiology. However, it faces challenges like motion artifacts, catheter-related discomfort, and difficulty measuring continuous bladder volume.</p><p><strong>Remote monitoring technologies: </strong>Emerging devices such as Urodynamics Monitor and UroSound offer more patient-friendly alternatives. These tools have the potential to improve diagnostic accuracy for bladder pressure and voiding metrics but remain limited and still require further validation and testing.</p><p><strong>Ultrasonography in uds: </strong>Ultrasound-based modalities, including dynamic ultrasonography and shear wave elastography, provide real-time, noninvasive assessment of bladder structure and function. These modalities are promising but will require further development of standardized protocols.</p><p><strong>Artificial intelligence in uds: </strong>AI and machine learning models enhance diagnostic accuracy and reduce variability in UDS interpretation. Applications include detecting detrusor overactivity and distinguishing bladder outlet obstruction from detrusor underactivity. However, further validation is required for clinical adoption.</p><p><strong>Conclusion: </strong>Advances in AUM, wearable technologies, ultrasonography, and AI demonstrate potential for transforming UDS into a more accurate, patient-centered tool. Despite significant progress, challenges like technical complexity, standardization, and cost-effectiveness must be addressed to integrate these innovations into routine practice. Nonetheless, these technologies provide the possibility of a future of improved diagnosis and treatment of lower urinary tract dysfunction.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"293-298"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144009098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Nocturia Management Through Sleep Apnea Diagnosis and Treatment. 通过睡眠呼吸暂停的诊断和治疗改善夜尿症的管理。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-03 DOI: 10.1002/nau.70187
F Pearce Kudlata, Stacy R Bedore, B S A Marc Gelernter, Luke G Scanlan, Om V Sakhalkar, Brittany Ange, Martha K Terris, Pablo J SantaMaria

Introduction/background: Obstructive sleep apnea (OSA) has an established association with nocturia, but even when referred, patients presenting with nocturia may not undergo a full evaluation or begin treatment for underlying OSA. At our institution, patients with nocturia (≥ 2 episodes per night) are often referred for at-home sleep studies. This study aims to assess if patients presenting with nocturia undergo evaluation for OSA and the impact of continuous or automatic positive airway pressure (CPAP/APAP) on nocturia severity.

Methods: We conducted a retrospective chart review of patients with nocturia who completed an at-home sleep study for OSA between July 2020 and September 2023. Patients with pre-existing OSA were excluded. Statistical analysis included Wilcoxon signed-rank tests and Kruskal-Wallis tests.

Results: Of 336 nocturia patients referred for sleep studies, 37 completed the study, and all met diagnostic criteria for OSA. Sixteen of those patients (43.2%) initiated CPAP/APAP therapy. In patients receiving nocturia medication, the mean nocturic episodes significantly decreased after CPAP/APAP initiation (p < 0.01). No significant change was observed before CPAP/APAP initiation with medical management alone (p = 0.052). Twelve of the 16 patients reported subjective improvement in lower urinary tract symptoms (LUTS).

Conclusion: All patients with nocturia who completed an at-home sleep study were diagnosed with OSA, yet most did not follow up, indicating potential underdiagnosis and undertreatment. As advancements in OSA treatment continue to be made, evaluation and treatment for OSA in patients presenting with nocturia may lead to improvement in both conditions.

简介/背景:阻塞性睡眠呼吸暂停(OSA)与夜尿症有明确的关联,但即使转诊,夜尿症患者也可能没有接受充分的评估或开始治疗潜在的OSA。在我们的机构,夜尿症患者(每晚≥2次)经常被推荐进行家庭睡眠研究。本研究旨在评估夜尿症患者是否接受OSA评估,以及持续或自动气道正压通气(CPAP/APAP)对夜尿症严重程度的影响。方法:我们对2020年7月至2023年9月期间完成OSA家庭睡眠研究的夜尿症患者进行了回顾性图表回顾。排除已有OSA患者。统计分析包括Wilcoxon sign -rank检验和Kruskal-Wallis检验。结果:在336例夜尿症患者中,37例完成了睡眠研究,均符合OSA的诊断标准。其中16例(43.2%)开始了CPAP/APAP治疗。在接受夜尿症药物治疗的患者中,CPAP/APAP启动后夜尿症平均发作次数显著减少(p结论:所有完成家庭睡眠研究的夜尿症患者都被诊断为OSA,但大多数患者没有随访,这表明可能存在诊断不足和治疗不足的情况。随着OSA治疗的不断进步,对夜尿症患者的OSA进行评估和治疗可能会导致两种情况的改善。
{"title":"Improving Nocturia Management Through Sleep Apnea Diagnosis and Treatment.","authors":"F Pearce Kudlata, Stacy R Bedore, B S A Marc Gelernter, Luke G Scanlan, Om V Sakhalkar, Brittany Ange, Martha K Terris, Pablo J SantaMaria","doi":"10.1002/nau.70187","DOIUrl":"10.1002/nau.70187","url":null,"abstract":"<p><strong>Introduction/background: </strong>Obstructive sleep apnea (OSA) has an established association with nocturia, but even when referred, patients presenting with nocturia may not undergo a full evaluation or begin treatment for underlying OSA. At our institution, patients with nocturia (≥ 2 episodes per night) are often referred for at-home sleep studies. This study aims to assess if patients presenting with nocturia undergo evaluation for OSA and the impact of continuous or automatic positive airway pressure (CPAP/APAP) on nocturia severity.</p><p><strong>Methods: </strong>We conducted a retrospective chart review of patients with nocturia who completed an at-home sleep study for OSA between July 2020 and September 2023. Patients with pre-existing OSA were excluded. Statistical analysis included Wilcoxon signed-rank tests and Kruskal-Wallis tests.</p><p><strong>Results: </strong>Of 336 nocturia patients referred for sleep studies, 37 completed the study, and all met diagnostic criteria for OSA. Sixteen of those patients (43.2%) initiated CPAP/APAP therapy. In patients receiving nocturia medication, the mean nocturic episodes significantly decreased after CPAP/APAP initiation (p < 0.01). No significant change was observed before CPAP/APAP initiation with medical management alone (p = 0.052). Twelve of the 16 patients reported subjective improvement in lower urinary tract symptoms (LUTS).</p><p><strong>Conclusion: </strong>All patients with nocturia who completed an at-home sleep study were diagnosed with OSA, yet most did not follow up, indicating potential underdiagnosis and undertreatment. As advancements in OSA treatment continue to be made, evaluation and treatment for OSA in patients presenting with nocturia may lead to improvement in both conditions.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"385-389"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: "Comparative Risk of Developing Interstitial Cystitis With Childhood Gastrointestinal, Urological, Autoimmune, or Psychiatric Disorders". 评论:“发生间质性膀胱炎与儿童胃肠道、泌尿系统、自身免疫或精神疾病的比较风险”。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-08-25 DOI: 10.1002/nau.70132
Muhammad Huzaifa Sabir, Muhammad Owais, Muhammad Nouman Javed
{"title":"Comment on: \"Comparative Risk of Developing Interstitial Cystitis With Childhood Gastrointestinal, Urological, Autoimmune, or Psychiatric Disorders\".","authors":"Muhammad Huzaifa Sabir, Muhammad Owais, Muhammad Nouman Javed","doi":"10.1002/nau.70132","DOIUrl":"10.1002/nau.70132","url":null,"abstract":"","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"417-418"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144963057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor on "Widespread Pain Moderates the Response to Centrally Acting Therapies in an Observational Cohort of Patients With Urologic Chronic Pelvic Pain Syndrome: A MAPP Research Network Study". 致编辑的信“在泌尿系统慢性盆腔疼痛综合征患者的观察队列中,广泛的疼痛调节对中枢作用治疗的反应:AMAPP研究网络研究”。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-20 DOI: 10.1002/nau.70192
Taha Yahya, Meer Hassan Khalid, Suleman Arshad, Syed Ali Raza Zaidi
{"title":"Letter to the Editor on \"Widespread Pain Moderates the Response to Centrally Acting Therapies in an Observational Cohort of Patients With Urologic Chronic Pelvic Pain Syndrome: A MAPP Research Network Study\".","authors":"Taha Yahya, Meer Hassan Khalid, Suleman Arshad, Syed Ali Raza Zaidi","doi":"10.1002/nau.70192","DOIUrl":"10.1002/nau.70192","url":null,"abstract":"","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"423-424"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urodynamics in Focus: Applications, Controversies, and Evolving Practices. 泌尿动力学的焦点:应用,争议和不断发展的实践。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-03 DOI: 10.1002/nau.70203
Joshua A Cohn, Brian J Linder
{"title":"Urodynamics in Focus: Applications, Controversies, and Evolving Practices.","authors":"Joshua A Cohn, Brian J Linder","doi":"10.1002/nau.70203","DOIUrl":"10.1002/nau.70203","url":null,"abstract":"","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"253"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Urodynamics in Assessing Lower Urinary Tract Symptoms Post-Radical Prostatectomy: A Review. 尿动力学在评估根治性前列腺切除术后下尿路症状中的作用:综述。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-10-09 DOI: 10.1002/nau.70157
Dora Jericevic Schwartz, Suditi Rahematpura, Benjamin Brucker

Introduction: This review examines the role of urodynamics (UDS) in evaluating lower urinary tract symptoms (LUTS) following radical prostatectomy. We first present typical urodynamic findings in post-prostatectomy men, then discuss applications of UDS, and finally examine treatment pathways for post-prostatectomy LUTS beyond stress urinary incontinence (SUI) surgery.

Methods: A narrative review was performed focusing on the current primary literature and society guidelines on the role of UDS post-prostatectomy.

Results: LUTS after prostatectomy are common, most frequently storage LUTS, specifically SUI. For the index patient with clinically suspected SUI after prostate treatment, routine UDS before SUI surgery have not been shown to impact postsurgical continence outcomes. In cases where there is diagnostic uncertainty following noninvasive lower urinary tract evaluation, UDS plays an important role. UDS are highly beneficial in complex scenarios, such as severe mixed LUTS, prior radiation therapy, impaired bladder compliance, detrusor underactivity, and/or previous SUI surgery. Fluoroscopy during UDS and cystoscopy can provide additional clarity and confirmation of the diagnosis suggested by UDS.

Conclusion: UDS are useful adjuncts in appropriately selected post-prostatectomy patients with LUTS, typically with complicating factors.

简介:本综述探讨了尿动力学(UDS)在评估根治性前列腺切除术后下尿路症状(LUTS)中的作用。我们首先介绍前列腺切除术后男性的典型尿动力学结果,然后讨论UDS的应用,最后探讨前列腺切除术后LUTS在压力性尿失禁(SUI)手术之外的治疗途径。方法:对目前主要文献和社会指南中关于UDS在前列腺切除术后的作用进行综述。结果:前列腺切除术后的LUTS是常见的,最常见的是存储LUTS,特别是SUI。对于前列腺治疗后临床怀疑SUI的指数患者,SUI术前常规UDS未显示对术后尿失禁结果的影响。在无创下尿路评估后诊断不确定的情况下,UDS发挥了重要作用。UDS在复杂情况下非常有用,如严重的混合性LUTS、既往放射治疗、膀胱顺应性受损、逼尿肌活动不足和/或既往SUI手术。超声造影和膀胱镜检查可进一步明确和确认超声造影建议的诊断。结论:UDS是适当选择的前列腺切除术后LUTS患者的有效辅助手段,通常伴有并发症。
{"title":"The Role of Urodynamics in Assessing Lower Urinary Tract Symptoms Post-Radical Prostatectomy: A Review.","authors":"Dora Jericevic Schwartz, Suditi Rahematpura, Benjamin Brucker","doi":"10.1002/nau.70157","DOIUrl":"10.1002/nau.70157","url":null,"abstract":"<p><strong>Introduction: </strong>This review examines the role of urodynamics (UDS) in evaluating lower urinary tract symptoms (LUTS) following radical prostatectomy. We first present typical urodynamic findings in post-prostatectomy men, then discuss applications of UDS, and finally examine treatment pathways for post-prostatectomy LUTS beyond stress urinary incontinence (SUI) surgery.</p><p><strong>Methods: </strong>A narrative review was performed focusing on the current primary literature and society guidelines on the role of UDS post-prostatectomy.</p><p><strong>Results: </strong>LUTS after prostatectomy are common, most frequently storage LUTS, specifically SUI. For the index patient with clinically suspected SUI after prostate treatment, routine UDS before SUI surgery have not been shown to impact postsurgical continence outcomes. In cases where there is diagnostic uncertainty following noninvasive lower urinary tract evaluation, UDS plays an important role. UDS are highly beneficial in complex scenarios, such as severe mixed LUTS, prior radiation therapy, impaired bladder compliance, detrusor underactivity, and/or previous SUI surgery. Fluoroscopy during UDS and cystoscopy can provide additional clarity and confirmation of the diagnosis suggested by UDS.</p><p><strong>Conclusion: </strong>UDS are useful adjuncts in appropriately selected post-prostatectomy patients with LUTS, typically with complicating factors.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"270-278"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145258592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Effectiveness of Botulinum Toxin a Versus Placebo for Neurogenic Overactive Bladder: A Meta-Analysis. a型肉毒毒素与安慰剂治疗神经源性膀胱过动症的疗效比较:荟萃分析。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2026-01-14 DOI: 10.1002/nau.70211
Konstantinos Tassoudis, Zachos Ioannis, Dimitropoulos Konstatninos, Evmorfopoulos Konstantinos, Marsitopoulos Konstantinos, Vassilios Tassoudis, Vassilios Tzortzis
<p><strong>Background: </strong>Lower urinary tract (LUT) dysfunctions affect millions of patients globally. LUT dysfunctions are extremely common in patients with neurological diseases. Worldwide, subtype A of Botulinum Toxin A (BTXA) is regularly used to treat these disorders.</p><p><strong>Introduction: </strong>LUT dysfunctions have various patterns of expression. The most prevalent of these is neurogenic detrusor overactivity (NDO), which is strongly associated with neurological diseases and can significantly impact a patient's life.</p><p><strong>Objective: </strong>Onabotulinumtoxin A is a widely used drug for the treatment of neurogenic bladder. The purpose of this study is to evaluate its efficacy and safety across different dosages in patients with the condition.</p><p><strong>Data sources: </strong>Pubmed, Scopus, Web of Science.</p><p><strong>Review methods: </strong>Systematic literature review was performed to identify randomized, double-blind, placebo-controlled trials of onabotulinumtoxin A for NDO. Seven randomized controlled trials were incorporated in this meta-analysis. The primary outcome concerned urodynamic parameters, including Maximum Cystometric Capacity (MCC) and Maximum Detrusor Pressure (MDP); the mean number of Urinary Incontinence (UI) episodes per week was also assessed. Safety was evaluated by the incidence of various Adverse Events (AE). Data was extracted by two authors and statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS v.29).</p><p><strong>Results: </strong>Seven RCTs involving 1592 patients in total were included in the study, following screening of 1602 potentially relevant articles. The Onabotulinumtoxin A-treated groups showed a significant increase in MCC (Mean Difference ([MD]: 128.866, 95% Confidence Interval [CI]: 98.836, 158.896, p < 0.001, in the group that received 200 Units of Onabotulinumtoxin A; MD: 151.389, CI: 106.006, 196.773, p < 0.005, in the group that received 300Units of Onabotulinumtoxin A). There was also a significant decrease in MDP in the Onabotulinumtoxin A-treated groups (MD: -29.051, CI: -39.557, -18.545, p < 0.002, 200 U group; MD: -31.751, CI: -45.226, -18.276, p < 0.01, 300 U group). Additionally, no effect was noticed in the mean number of UI episodes per week (MD: -10.69, 95% CI: -33.86, 12.49, p = 0.11; MD: -10.55, 95% CI: -59.06, 37.97, p = 0.22, 200 U and 300 U respectively). Taking AEs into consideration, Onabotulinumtoxin A-treated groups were often associated with more complications, including urinary tract infections (UTI) (LogOR: 0.341, CI: 0.011, 0.67, p = 0.045, 200 U group; LogOR: 0.424, CI: 0.075, 0.773, p = 0.028, 300 U group) and urinary retention (UR) (LogOR: 1.746, CI: 0.869, 2.623, p = 0.008, 200 U group; LogOR: 1.879, CI: 0.679, 3.078, p = 0.021, 300 U group).</p><p><strong>Conclusions: </strong>Our meta-analyses found that Onabotulinumtoxin A can be beneficial in improving the urodynamic parameters (MCC and M
背景:下尿路(LUT)功能障碍影响着全球数百万患者。LUT功能障碍在神经系统疾病患者中极为常见。在世界范围内,A型肉毒毒素A (BTXA)经常用于治疗这些疾病。LUT功能障碍具有多种表达模式。其中最常见的是神经源性逼尿肌过度活动(NDO),这与神经系统疾病密切相关,并可能严重影响患者的生活。目的:肉毒杆菌毒素A是一种广泛应用于治疗神经源性膀胱的药物。本研究的目的是评估其在不同剂量下对患者的疗效和安全性。数据来源:Pubmed, Scopus, Web of Science。综述方法:采用系统的文献综述来确定肉毒杆菌毒素A治疗NDO的随机、双盲、安慰剂对照试验。本荟萃分析纳入了7项随机对照试验。主要结局涉及尿动力学参数,包括最大膀胱容量(MCC)和最大逼尿肌压力(MDP);每周尿失禁(UI)发作的平均次数也被评估。通过各种不良事件(AE)的发生率来评估安全性。数据由两位作者提取,并使用社会科学统计软件包(SPSS v.29)进行统计分析。结果:在筛选了1602篇可能相关的文章后,共纳入了7项随机对照试验,共涉及1592例患者。单肉毒杆菌毒素a治疗组MCC显著升高(平均差值[MD]: 128.866, 95%可信区间[CI]: 98.836, 158.896, p)。结论:我们的荟萃分析发现单肉毒杆菌毒素a可改善尿动力学参数(MCC和MDP)。就安全性而言,药物治疗组发生尿路感染或尿路感染的可能性略高。
{"title":"Comparative Effectiveness of Botulinum Toxin a Versus Placebo for Neurogenic Overactive Bladder: A Meta-Analysis.","authors":"Konstantinos Tassoudis, Zachos Ioannis, Dimitropoulos Konstatninos, Evmorfopoulos Konstantinos, Marsitopoulos Konstantinos, Vassilios Tassoudis, Vassilios Tzortzis","doi":"10.1002/nau.70211","DOIUrl":"10.1002/nau.70211","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Lower urinary tract (LUT) dysfunctions affect millions of patients globally. LUT dysfunctions are extremely common in patients with neurological diseases. Worldwide, subtype A of Botulinum Toxin A (BTXA) is regularly used to treat these disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;LUT dysfunctions have various patterns of expression. The most prevalent of these is neurogenic detrusor overactivity (NDO), which is strongly associated with neurological diseases and can significantly impact a patient's life.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Onabotulinumtoxin A is a widely used drug for the treatment of neurogenic bladder. The purpose of this study is to evaluate its efficacy and safety across different dosages in patients with the condition.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data sources: &lt;/strong&gt;Pubmed, Scopus, Web of Science.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Review methods: &lt;/strong&gt;Systematic literature review was performed to identify randomized, double-blind, placebo-controlled trials of onabotulinumtoxin A for NDO. Seven randomized controlled trials were incorporated in this meta-analysis. The primary outcome concerned urodynamic parameters, including Maximum Cystometric Capacity (MCC) and Maximum Detrusor Pressure (MDP); the mean number of Urinary Incontinence (UI) episodes per week was also assessed. Safety was evaluated by the incidence of various Adverse Events (AE). Data was extracted by two authors and statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS v.29).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Seven RCTs involving 1592 patients in total were included in the study, following screening of 1602 potentially relevant articles. The Onabotulinumtoxin A-treated groups showed a significant increase in MCC (Mean Difference ([MD]: 128.866, 95% Confidence Interval [CI]: 98.836, 158.896, p &lt; 0.001, in the group that received 200 Units of Onabotulinumtoxin A; MD: 151.389, CI: 106.006, 196.773, p &lt; 0.005, in the group that received 300Units of Onabotulinumtoxin A). There was also a significant decrease in MDP in the Onabotulinumtoxin A-treated groups (MD: -29.051, CI: -39.557, -18.545, p &lt; 0.002, 200 U group; MD: -31.751, CI: -45.226, -18.276, p &lt; 0.01, 300 U group). Additionally, no effect was noticed in the mean number of UI episodes per week (MD: -10.69, 95% CI: -33.86, 12.49, p = 0.11; MD: -10.55, 95% CI: -59.06, 37.97, p = 0.22, 200 U and 300 U respectively). Taking AEs into consideration, Onabotulinumtoxin A-treated groups were often associated with more complications, including urinary tract infections (UTI) (LogOR: 0.341, CI: 0.011, 0.67, p = 0.045, 200 U group; LogOR: 0.424, CI: 0.075, 0.773, p = 0.028, 300 U group) and urinary retention (UR) (LogOR: 1.746, CI: 0.869, 2.623, p = 0.008, 200 U group; LogOR: 1.879, CI: 0.679, 3.078, p = 0.021, 300 U group).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our meta-analyses found that Onabotulinumtoxin A can be beneficial in improving the urodynamic parameters (MCC and M","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"335-352"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurourology and Urodynamics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1